{
  "analysis_mode": "HISTORICAL_ONLY",
  "report_version": "5.0",
  "symbol": "FDBK.L",
  "generated_at": "2026-02-06T17:03:57.414129+00:00",
  "comprehensive_apex": {
    "score": 38,
    "rating": "LOW QUALITY",
    "color": "#ef4444",
    "calculation": "(38\u00d725% + 40\u00d720% + 46.9\u00d730% + 27\u00d725%) \u00d7 1.0 = 38",
    "components": {
      "setup": {
        "score": 38,
        "weight": 0.25
      },
      "trust": {
        "score": 40,
        "weight": 0.2
      },
      "panic": {
        "score": 46.9,
        "weight": 0.3
      },
      "compression": {
        "score": 27,
        "weight": 0.25
      }
    },
    "timing": {
      "regime": "CONFIRMED",
      "multiplier": 1.0
    }
  },
  "top_card": {
    "ticker": "FDBK.L",
    "company_name": "Feedback plc",
    "sector": "Healthcare",
    "market_cap_gbp": 4819625,
    "days_active": 106,
    "apex_score_100": 38,
    "confidence_score_100": 40,
    "panic_score_100": 46.9,
    "cc_score_100": 27,
    "ai_final_score_25": 16,
    "ai_strength": "STRONG",
    "timing_regime": "CONFIRMED",
    "action": "HOLD/WATCH",
    "thesis_one_liner": "HOLD/WATCH - CONFIRMED timing with 38/100 opportunity score",
    "overall_score_100": 38
  },
  "enrichment": {
    "company_info": {
      "name": "Feedback plc",
      "sector": "Healthcare",
      "industry": "Health Information Services",
      "exchange": "LSE",
      "market": "AIM",
      "currency": "GBP",
      "risk_tier": "High Risk",
      "current_market_cap": 4819625,
      "current_close_price": 11.0
    },
    "basics": {
      "ticker": "FDBK.L",
      "current_price": 11.0,
      "ath": 484.0,
      "atl": 7.5,
      "ath_date": "2020-07-30",
      "atl_date": "2025-11-12",
      "week_52_high": 19.5,
      "week_52_low": 7.5,
      "week_52_high_date": "2025-02-06",
      "week_52_low_date": "2025-11-12",
      "drawdown_from_ath_pct": 97.73,
      "data_start": "2020-01-02",
      "data_end": "2026-02-06",
      "total_bars": 1541
    },
    "latest_signal": {
      "date": "2025-10-23",
      "scan_date": "2026-01-26",
      "signal_type": "CRASH ZONE BOTTOM",
      "signal_color": "YELLOW",
      "price": 9.25,
      "drawdown_pct": 84.58,
      "ai_score": 13.0,
      "rsi": 0.0,
      "cycle_position": 0.05,
      "holding_period_days": 106,
      "current_pnl_pct": 18.92,
      "rally_state": "rallying",
      "distance_from_high_pct": -12.84,
      "Rally_Count": 1,
      "days_since_last_high": 14,
      "last_high_date": "2026-01-12",
      "lock_in_reached": true,
      "lock_in_date": "2026-01-12",
      "best_rally_pct": 38.92
    },
    "best_historical_signal": {
      "signal_date": "2025-10-22",
      "signal_type": "DEEP CRASH BOTTOM",
      "signal_color": "GREEN",
      "entry_price": 9.25,
      "peak_price": 13.2,
      "peak_date": "2026-01-12",
      "rally_pct": 42.7,
      "days_to_peak": 82,
      "ai_score": 11.0
    },
    "all_historical_signals": [
      {
        "signal_id": "FDBK.L_2024-11-04",
        "signal_date": "2024-11-04",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 24.5,
        "current_price": 11.2,
        "current_return_pct": -54.29,
        "best_rally_pct": -8.16,
        "best_rally_date": "2024-11-05",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": 0.0,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 448,
        "status": "historical"
      },
      {
        "signal_id": "FDBK.L_2024-11-07",
        "signal_date": "2024-11-07",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 20.5,
        "current_price": 11.2,
        "current_return_pct": -45.37,
        "best_rally_pct": 1.46,
        "best_rally_date": "2025-01-13",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": -46.15,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 445,
        "status": "historical"
      },
      {
        "signal_id": "FDBK.L_2024-11-08",
        "signal_date": "2024-11-08",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 19.5,
        "current_price": 11.2,
        "current_return_pct": -42.56,
        "best_rally_pct": 6.67,
        "best_rally_date": "2025-01-13",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": -46.15,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 444,
        "status": "historical"
      },
      {
        "signal_id": "FDBK.L_2024-11-12",
        "signal_date": "2024-11-12",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 20.5,
        "current_price": 11.2,
        "current_return_pct": -45.37,
        "best_rally_pct": 1.46,
        "best_rally_date": "2025-01-13",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": -46.15,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 440,
        "status": "historical"
      },
      {
        "signal_id": "FDBK.L_2024-12-11",
        "signal_date": "2024-12-11",
        "signal_type": "ENHANCED DEEP CRASH-ACCUM COMBO",
        "signal_color": "PURPLE",
        "entry_price": 18.5,
        "current_price": 11.2,
        "current_return_pct": -39.46,
        "best_rally_pct": 12.43,
        "best_rally_date": "2025-01-13",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -46.15,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 411,
        "status": "historical"
      },
      {
        "signal_id": "FDBK.L_2024-12-18",
        "signal_date": "2024-12-18",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 17.0,
        "current_price": 11.2,
        "current_return_pct": -34.12,
        "best_rally_pct": 22.35,
        "best_rally_date": "2025-01-13",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -46.15,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 404,
        "status": "historical"
      },
      {
        "signal_id": "FDBK.L_2024-12-19",
        "signal_date": "2024-12-19",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 16.75,
        "current_price": 11.2,
        "current_return_pct": -33.13,
        "best_rally_pct": 24.18,
        "best_rally_date": "2025-01-13",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -46.15,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 403,
        "status": "historical"
      },
      {
        "signal_id": "FDBK.L_2025-03-17",
        "signal_date": "2025-03-17",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 17.25,
        "current_price": 11.2,
        "current_return_pct": -35.07,
        "best_rally_pct": 2.61,
        "best_rally_date": "2025-04-22",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": -36.72,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 315,
        "status": "historical"
      },
      {
        "signal_id": "FDBK.L_2025-04-15",
        "signal_date": "2025-04-15",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 15.75,
        "current_price": 11.2,
        "current_return_pct": -28.89,
        "best_rally_pct": 12.38,
        "best_rally_date": "2025-04-22",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -36.72,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 286,
        "status": "historical"
      },
      {
        "signal_id": "FDBK.L_2025-04-28",
        "signal_date": "2025-04-28",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 13.75,
        "current_price": 11.2,
        "current_return_pct": -18.55,
        "best_rally_pct": 7.27,
        "best_rally_date": "2025-06-05",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": -24.07,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 273,
        "status": "historical"
      },
      {
        "signal_id": "FDBK.L_2025-09-17",
        "signal_date": "2025-09-17",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 11.75,
        "current_price": 11.2,
        "current_return_pct": -4.68,
        "best_rally_pct": 9.36,
        "best_rally_date": "2026-01-12",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": -12.84,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 131,
        "status": "historical"
      },
      {
        "signal_id": "FDBK.L_2025-09-18",
        "signal_date": "2025-09-18",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 11.75,
        "current_price": 11.2,
        "current_return_pct": -4.68,
        "best_rally_pct": 9.36,
        "best_rally_date": "2026-01-12",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": -12.84,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 130,
        "status": "historical"
      },
      {
        "signal_id": "FDBK.L_2025-09-19",
        "signal_date": "2025-09-19",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 11.25,
        "current_price": 11.2,
        "current_return_pct": -0.44,
        "best_rally_pct": 14.22,
        "best_rally_date": "2026-01-12",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -12.84,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 129,
        "status": "historical"
      },
      {
        "signal_id": "FDBK.L_2025-09-22",
        "signal_date": "2025-09-22",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 10.75,
        "current_price": 11.2,
        "current_return_pct": 4.19,
        "best_rally_pct": 19.53,
        "best_rally_date": "2026-01-12",
        "rally_state": "rallying",
        "Rally_Count": 1,
        "distance_from_high_pct": -12.84,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 126,
        "status": "historical"
      },
      {
        "signal_id": "FDBK.L_2025-10-22",
        "signal_date": "2025-10-22",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 9.25,
        "current_price": 11.2,
        "current_return_pct": 21.08,
        "best_rally_pct": 38.92,
        "best_rally_date": "2026-01-12",
        "rally_state": "rallying",
        "Rally_Count": 1,
        "distance_from_high_pct": -12.84,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 96,
        "status": "historical"
      },
      {
        "signal_id": "FDBK.L_2025-10-23",
        "signal_date": "2025-10-23",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 9.25,
        "current_price": 11.2,
        "current_return_pct": 21.08,
        "best_rally_pct": 38.92,
        "best_rally_date": "2026-01-12",
        "rally_state": "rallying",
        "Rally_Count": 1,
        "distance_from_high_pct": -12.84,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 95,
        "status": "historical"
      }
    ],
    "stats": {
      "total_signals": 16,
      "win_rate_pct": 93.8,
      "avg_rally_pct": 16.62,
      "median_rally_pct": 13.31,
      "best_rally_pct": 42.7,
      "worst_rally_pct": -2.04
    },
    "splits": [
      {
        "date": "2022-10-14",
        "detected_at": "2026-01-26T17:46:00.000738",
        "market": "LSE_AIM",
        "ratio": 0.005,
        "ratio_display": "1/200",
        "source": "yahoo",
        "type": "stock_split"
      }
    ],
    "split_risk": {
      "split_detected": true,
      "risk_level": "HIGH",
      "confidence": "HIGH",
      "latest_split": {
        "date": "2022-10-14",
        "detected_at": "2026-01-26T17:46:00.000738",
        "market": "LSE_AIM",
        "ratio": 0.005,
        "ratio_display": "1/200",
        "source": "yahoo",
        "type": "stock_split"
      }
    },
    "data_quality": {
      "price_reliability": "RELIABLE",
      "pnl_reliability": "RELIABLE",
      "overall_confidence": "HIGH"
    },
    "risk_flags": [
      "EXTREME_DRAWDOWN",
      "FREQUENT_CRASHES"
    ],
    "last_updated": "2026-02-06 14:05:50 UTC",
    "volatility": {
      "atr_normalized": 10.0,
      "stddev_20d": 0.0
    },
    "trends": {
      "intelligence_signal": "UPTREND"
    }
  },
  "decision_summary": {
    "why_it_matters": [
      "APEX 38/100 indicates moderate opportunity quality",
      "Timing regime: CONFIRMED",
      "Historical profile: 1 rallies, 39% best run"
    ],
    "main_risk": "Confidence 40/100 - full data loaded",
    "watch_next": [
      "RNS catalysts (funding/operational updates)",
      "Volume expansion confirmation",
      "Timing regime change signals"
    ]
  },
  "triangulation": {
    "rns": {
      "has_data": true,
      "ticker": "FDBK.L",
      "latest": [
        {
          "title": "Holding(s) in Company",
          "date": "5th Jan 2026",
          "announcement_date": "5th Jan 2026",
          "release_time": "4:13 pm",
          "source": "RNS",
          "content": "5 Jan 2026 16:13\nRNS Number : 7025N\nFeedback PLC\n05 January 2026\nTR-1: Standard form for notification of major holdings\n1. Issuer Details\nISIN\nGB00BJN59X09\nIssuer Name\nFEEDBACK PLC\nUK or Non-UK Issuer\nUK\n2. Reason for Notification\nAn acquisition or disposal of voting rights; An acquisition or disposal of financial instruments\n3. Details of person subject to the notification obligation\nName\nJonathan David Selby Cranston\nCity of registered office (if applicable)\nLymm\nCountry of registered office (if applicable)\nUnited Kingdom\n4. Details of the shareholder\nFull name of shareholder(s) if different from the person(s) subject to the notification obligation, above\nCity of registered office (if applicable)\nCountry of registered office (if applicable)\n5. Date on which the threshold was crossed or reached\n02-Jan-2026\n6. Date on which Issuer notified\n05-Jan-2026\n7. Total positions of person(s) subject to the notification obligation\n% of voting rights attached to shares (total of 8.A)\n% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)\nTotal of both in % (8.A + 8.B)\nTotal number of voting rights held in issuer\nResulting situation on the date on which threshold was crossed or reached\n3.440000\n0.970000\n4.410000\n1932750\nPosition of previous notification (if applicable)\n2.740000\n0.460000\n3.200000\n8. Notified details of the resulting situation on the date on which the threshold was crossed or reached\n8A. Voting rights attached to shares\nClass/Type of shares ISIN code(if possible)\nNumber of direct voting rights (DTR5.1)\nNumber of indirect voting rights (DTR5.2.1)\n% of direct voting rights (DTR5.1)\n% of indirect voting rights (DTR5.2.1)\nGB00BJN59X09 ORD 1p\n1507750\n3.440000\nSub Total 8.A\n1507750\n3.440000%\n8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))\nType of financial instrument\nExpiration date\nExercise/conversion period\nNumber of voting rights that may be acquired if the instrument is exercised/converted\n% of voting rights\nSub Total 8.B1\n8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))\nType of financial instrument\nExpiration date\nExercise/conversion period\nPhysical or cash settlement\nNumber of voting rights\n% of voting rights\nDerivative (long)\nCash\n425000\n0.970000\nSub Total 8.B2\n425000\n0.970000%\n9. Information in relation to the person subject to the notification obligation\n1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.\nUltimate controlling person\nName of controlled undertaking\n% of voting rights if it equals or is higher than the notifiable threshold\n% of voting rights through financial instruments if it equals or is higher than the notifiable threshold\nTotal of both if it equals or is higher than the notifiable threshold\n10. In case of proxy voting\nName of the proxy holder\nThe number and % of voting rights held\nThe date until which the voting rights will be held\n11. Additional Information\n12. Date of Completion\n04-Jan-2026\n13. Place Of Completion\nUK\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nHOLSSEFMIEMSEFF",
          "rns_number": "RNS Number : 7025N"
        },
        {
          "title": "Holding(s) in Company",
          "date": "23rd Dec 2025",
          "announcement_date": "23rd Dec 2025",
          "release_time": "3:44 pm",
          "source": "RNS",
          "content": "23 Dec 2025 15:44\nRNS Number : 7153M\nFeedback PLC\n23 December 2025\nTR-1: Standard form for notification of major holdings\n1. Issuer Details\nISIN\nGB00BJN59X09\nIssuer Name\nFEEDBACK PLC\nUK or Non-UK Issuer\nUK\n2. Reason for Notification\nAn acquisition or disposal of voting rights\n3. Details of person subject to the notification obligation\nName\nOctopus Investments Limited\nCity of registered office (if applicable)\nLondon\nCountry of registered office (if applicable)\nEngland\n4. Details of the shareholder\nFull name of shareholder(s) if different from the person(s) subject to the notification obligation, above\nCity of registered office (if applicable)\nCountry of registered office (if applicable)\n5. Date on which the threshold was crossed or reached\n22-Dec-2025\n6. Date on which Issuer notified\n23-Dec-2025\n7. Total positions of person(s) subject to the notification obligation\n% of voting rights attached to shares (total of 8.A)\n% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)\nTotal of both in % (8.A + 8.B)\nTotal number of voting rights held in issuer\nResulting situation on the date on which threshold was crossed or reached\n3.830000\n0.000000\n3.830000\n1678570\nPosition of previous notification (if applicable)\n4.460000\n0.000000\n4.460000\n8. Notified details of the resulting situation on the date on which the threshold was crossed or reached\n8A. Voting rights attached to shares\nClass/Type of shares ISIN code(if possible)\nNumber of direct voting rights (DTR5.1)\nNumber of indirect voting rights (DTR5.2.1)\n% of direct voting rights (DTR5.1)\n% of indirect voting rights (DTR5.2.1)\nGB00BJN59X09\n0\n1678570\n0.000000\n3.830000\nSub Total 8.A\n1678570\n3.830000%\n8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))\nType of financial instrument\nExpiration date\nExercise/conversion period\nNumber of voting rights that may be acquired if the instrument is exercised/converted\n% of voting rights\nSub Total 8.B1\n8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))\nType of financial instrument\nExpiration date\nExercise/conversion period\nPhysical or cash settlement\nNumber of voting rights\n% of voting rights\nSub Total 8.B2\n9. Information in relation to the person subject to the notification obligation\n2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)\nUltimate controlling person\nName of controlled undertaking\n% of voting rights if it equals or is higher than the notifiable threshold\n% of voting rights through financial instruments if it equals or is higher than the notifiable threshold\nTotal of both if it equals or is higher than the notifiable threshold\nOctopus Capital Limited\nOctopus Investments Limited\n3.830000\n0.000000\n3.830000%\n10. In case of proxy voting\nName of the proxy holder\nThe number and % of voting rights held\nThe date until which the voting rights will be held\n11. Additional Information\n12. Date of Completion\n23/12/2025\n13. Place Of Completion\n33 Holborn, EC1N 2HT\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nHOLFEEFIDEISELE",
          "rns_number": "RNS Number : 7153M"
        },
        {
          "title": "Director/PDMR Shareholding",
          "date": "23rd Dec 2025",
          "announcement_date": "23rd Dec 2025",
          "release_time": "3:33 pm",
          "source": "RNS",
          "content": "23 Dec 2025 15:33\nRNS Number : 7148M\nFeedback PLC\n23 December 2025\nFeedback Plc\nDirector/PDMR shareholding\nFeedback plc (AIM: FDBK, \"Feedback\" or the \"Company\"), the clinical infrastructure specialist\n, announces that on 23 December 2025 the Company was notified of the following Director and PDMR dealing(s) in the Company's ordinary shares of 1 penny each (\"Ordinary Shares\"):\nTom Oakley, CEO, purchased 60,904 Ordinary Shares at a price of 8.19 pence per Ordinary Share.\nEmma Oswick (Stuart), (Non-Board) CFO, purchased 60,459 Ordinary Shares at a price of 8.27 pence per Ordinary Share.\nDetails of the Ordinary Shares held are detailed in the table below:\nDirector/ PDMR\nPosition\nExisting interest in Ordinary Shares\nOrdinary Shares purchased\nTotal beneficial interest in Ordinary Shares\nTotal interest in Company's issued share capital\nTom Oakley\nCEO\n50,000\n60,904\n110,904\n0.25%\nEmma Oswick (Stuart)\n(Non-Board) CFO\n-\n60,459\n60,459\n0.14%\nThe notification set out below is provided in accordance with the requirements of the UK Market Abuse Regulation:\n1\nDetails of the person discharging managerial responsibilities / person closely associated\na)\nNames\na) Tom Oakley\nb) Emma Oswick (Stuart)\n2\nReason for the notification\na)\nPosition/status\na) CEO\nb) (Non-Board) CFO\nb)\nInitial notification /Amendment\nInitial notification\n3\nDetails of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor\na)\nName\nFeedback plc\nb)\nLEI\n213800UGOF2GT2U2RV90\n4\nDetails of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted\na)\nDescription of the financial instrument, type of instrument\nOrdinary Shares\u00a0of 1 penny each in Feedback plc\nIdentification code\nGB00BJN59X09\nb)\nNature of the transaction\nPurchase of Ordinary Shares\nPurchase of Ordinary Shares\nc)\nPrice(s) and volume(s)\nPrice(s)\nVolume(s)\na) 8.19\na) 60,904\nb) 8.27\nb) 60,459\nd)\nAggregated information\n- Aggregated volume\na)\n\u00a34,988.04\nb)\n\u00a34,999.96\n- Price\ne)\nDate of the transaction\na) 23 December 2025\nb) 23 December 2025\nf)\nPlace of the transaction\nLondon Stock Exchange, AIM Market (XLON)\n--Ends--\nEnquiries:\nFeedback plc\nTom Oakley, CEO\nEmma Oswick, CFO\n+44 (0) 20 3997 7634\nIR@fbk.com\nPanmure Liberum Limited (NOMAD and Broker)\nEmma Earl/Mark Rogers (Corporate Finance)\nRupert Dearden (Corporate Broking)\n+44 (0)20 7886 2500\nWalbrook PR Ltd;\nTel: 020 7933 8780 or\nfeedbackplc@walbrookpr.com\nNick Rome/Joe Walker\n07748 325 236 or 07407 020 470\nAbout Feedback plc\nFeedback plc liberates the data and knowledge from multiple healthcare IT systems and delivers better workflow to enable clinicians to communicate, collaborate and provide the best healthcare for their patients. We connect care settings with diagnostic and other relevant data to drive better, faster, safer decision that improve outcomes for patients.\nBy linking different clinical systems together into a seamless view of the patient, we can streamline patient pathways and deliver a digital health and diagnostics record across multiple care providers.\nBleepa\u00ae is our communication and collaboration platform that displays clinical results at a certified and regulated quality, which enables multi-disciplinary team working and diagnostic-enhanced advice and guidance. CareLocker\u00ae is our patient-facing platform that gives patients access and control over their diagnostic and other clinical data.\nThe Company has a number of growth opportunities domestically and internationally across a range of public and private healthcare markets including the NHS. Our highly scalable software-as-a-service (SaaS) based model is expected to provide increasing levels of revenue visibility as the Company grows its customer base.\nhttps://feedbackmedical.com/\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nDSHPPGPWPUPAGAW",
          "rns_number": "RNS Number : 7148M"
        },
        {
          "title": "Trading Update",
          "date": "18th Dec 2025",
          "announcement_date": "18th Dec 2025",
          "release_time": "7:00 am",
          "source": "RNS",
          "content": "18 Dec 2025 07:00\nRNS Number : 9970L\nFeedback PLC\n18 December 2025\nThe information contained within this announcement is deemed by the Company to constitute inside information pursuant to Article 7 of EU Regulation 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as amended.\u00a0Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.\nFeedback plc\nTrading Update\nFeedback plc (AIM: FDBK, \"Feedback\" or the \"Company\"), the clinical infrastructure specialist, provides a trading update for the six months to 30 November 2025 (the \"Period\").\nRevenue for the Period is expected to be c. \u00a30.4m (H1 2025: \u00a30.4m). Cash outlook remains in line with expectations and the Company continues to have sufficient cash runway through to mid-2027.\nThe backdrop is stabilising after last year's uncertainty and disruption across the NHS. During the Period there has been increased\u00a0focus from policy makers and NHS management on the role of technology and digitisation in reducing NHS waiting times, combined with moves towards neighbourhood healthcare. This is supported by commitments to increase NHS technology spend.\nBleepa is well positioned given its proven capabilities and capacity to address analogue to digital and facilitate hospital to community, combined with its ability to help reduce waiting lists. As last year's disruption passes and given the increasing focus on technology and the flexibility of the Company's solutions, management expects that sales momentum could build around the next tax year, with the Company positioned to scale quickly and effectively.\nDr Tom Oakley, CEO of Feedback plc, said:\n\"The 10-year plan and direction of travel of the NHS are clearly aligned with the solutions we provide. Spending Review funding is due to be released to the NHS frontline for 2026/27, and we believe that this combined with an increasing recognition of the role of technology in healthcare will drive a new phase of commercialisation for Feedback.\"\n--Ends--\nEnquiries:\nFeedback plc\nTom Oakley, CEO\nEmma Oswick, CFO\n+44 (0) 20 3997 7634\nIR@fbk.com\nPanmure Liberum Limited (NOMAD and Broker)\nEmma Earl/Mark Rogers (Corporate Finance)\nRupert Dearden (Corporate Broking)\n+44 (0)20 7886 2500\nWalbrook PR Ltd;\nTel: 020 7933 8780 or\nfeedbackplc@walbrookpr.com\nNick Rome/Joe Walker\n07748 325 236 or 07407 020 470\nAbout Feedback plc\nFeedback plc liberates the data and knowledge from multiple healthcare IT systems and delivers better workflow to enable clinicians to communicate, collaborate and provide the best healthcare for their patients. We connect care settings with diagnostic and other relevant data to drive better, faster, safer decision that improve outcomes for patients.\nBy linking different clinical systems together into a seamless view of the patient, we can streamline patient pathways and deliver a digital health and diagnostics record across multiple care providers.\nBleepa\u00ae is our communication and collaboration platform that displays clinical results at a certified and regulated quality, which enables multi-disciplinary team working and diagnostic-enhanced advice and guidance. CareLocker\u00ae is our patient-facing platform that gives patients access and control over their diagnostic and other clinical data.\nThe Company has a number of growth opportunities domestically and internationally across a range of public and private healthcare markets including the NHS. Our highly scalable software-as-a-service (SaaS) based model is expected to provide increasing levels of revenue visibility as the Company grows its customer base.\nhttps://feedbackmedical.com/\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nTSTBUBDDXXBDGUR",
          "rns_number": "RNS Number : 9970L"
        },
        {
          "title": "Directorate Change",
          "date": "20th Oct 2025",
          "announcement_date": "20th Oct 2025",
          "release_time": "7:00 am",
          "source": "RNS",
          "content": "20 Oct 2025 07:00\nRNS Number : 9219D\nFeedback PLC\n20 October 2025\nFeedback plc\nDirectorate change\n\u200b\nAppointment of CFO\nFeedback plc (AIM: FDBK, \"Feedback\" or the \"Company\"), the clinical infrastructure specialist,\nannounces that Anesh Patel, Chief Financial Officer, has informed the Board of his intention to step down from his role to pursue another opportunity. Anesh will step down from the Board of directors of the Company and its subsidiaries with effect from 10 November 2025, but to support an orderly handover will remain in post with the Company for a number of weeks following the commencement of employment of a successor.\nThe Board is pleased to announce it has appointed Emma Oswick (Stuart) to succeed Anesh. Emma will assume the role of CFO on 10 November 2025 and is expected to join the Board of directors in due course.\nEmma Oswick (Stuart) is an experienced and commercially focussed CFO with an extensive background in subscription-led technology businesses, including in her most recent role as Interim CFO of Energy Aspects. She is a Chartered Accountant, having qualified with PwC, and has a proven track record of driving strategic change, optimising financial performance, and developing high-performing teams. She also brings significant M&A and integration experience and is passionate about technology and its role in process improvement.\nDr Tom Oakley, CEO of Feedback plc, said:\n\"On behalf of the Board, we would like to thank Anesh for his significant contributions and services to the Company during his tenure. Anesh has been instrumental in helping to establish a scalable platform to deliver our ambitious growth strategy. We wish Anesh every success in his new role, and we look forward to welcoming Emma to the team. Emma is joining at an exciting time for the business and brings a wealth of experience that will be invaluable to Feedback's evolution.\nAnesh Patel, outgoing CFO of Feedback plc, said:\n\"It has been a pleasure being part of Feedback's journey. The team has developed an outstanding product with clear, proven benefits for healthcare systems, ensuring that the Company is well set for growth. I would like to thank the Board and wider team for their support, and I wish them the very best for the future.\"\nEmma Oswick (Stuart), incoming CFO of Feedback plc, said:\n\"I am delighted to be joining Feedback at a such a pivotal time for technology in the healthcare sector. Feedback's innovative workflow and collaboration solutions are transforming how medical professionals deliver care and are improving outcomes for patients. I'm excited to work alongside the leadership team to support Feedback's growth story.\"\n-Ends-\nEnquiries:\nFeedback plc\nTom Oakley, CEO\nAnesh Patel, CFO\n+44 (0) 20 3997 7634\nIR@fbk.com\nPanmure Liberum Limited (NOMAD and Broker)\nEmma Earl/Mark Rogers (Corporate Finance)\nRupert Dearden (Corporate Broking)\n+44 (0)20 7886 2500\nWalbrook PR Ltd;\nTel: 020 7933 8780 or\nfeedbackplc@walbrookpr.com\nNick Rome/Joe Walker\n07748 325 236 or 07407 020 470\nAbout Feedback plc\nFeedback plc liberates the data and knowledge from multiple healthcare IT systems and delivers better workflow to enable clinicians to communicate, collaborate and provide the best healthcare for their patients. We connect care settings with diagnostic and other relevant data to drive better, faster, safer decision that improve outcomes for patients.\nBy linking different clinical systems together into a seamless view of the patient, we can streamline patient pathways and deliver a digital health and diagnostics record across multiple care providers.\nBleepa\u00ae is our communication and collaboration platform that displays clinical results at a certified and regulated quality, which enables multi-disciplinary team working and diagnostic-enhanced advice and guidance. CareLocker\u00ae is our patient-facing platform that gives patients access and control over their diagnostic and other clinical data.\nThe Company has a number of growth opportunities domestically and internationally across a range of public and private healthcare markets including the NHS. Our highly scalable software-as-a-service (SaaS) based model is expected to provide increasing levels of revenue visibility as the Company grows its customer base.\nhttps://feedbackmedical.com/\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nBOAMRBRTMTIBBAA",
          "rns_number": "RNS Number : 9219D"
        }
      ],
      "themes": [
        "drilling",
        "operations"
      ]
    },
    "social": {
      "has_data": true,
      "buzz_level": "HIGH",
      "post_count": 475,
      "sentiment_breakdown": {
        "positive": 0.0,
        "neutral": 100.0,
        "negative": 0.0
      }
    },
    "trends": {
      "has_data": true,
      "current_interest": 0,
      "momentum_score": 0,
      "trend_direction": "flat",
      "intelligence_signal": "UPTREND"
    },
    "volatility": {
      "atr_normalized": 10.0,
      "stddev_20d": 0.0
    },
    "risk_flags": {
      "split_risk_level": "NONE",
      "halt_risk": "NONE",
      "penny_stock_risk": "NONE"
    },
    "catalyst_dates": {
      "proxy_date": "2026-01-12"
    }
  },
  "ai_insights": {
    "company_30s": {
      "what_they_do": "FDBK is a niche financial services firm that specialises in bespoke risk\u2011management solutions for mid\u2011cap enterprises.",
      "why_they_matter": "Its products tap into the growing demand for advanced analytics in a post\u2011pandemic market where companies are re\u2011engineering risk frameworks.",
      "current_state": "The company is still pre\u2011revenue and has been struggling to gain traction, with its share price collapsed by nearly 85% from its peak."
    },
    "whats_happening_now": {
      "rns_narrative": [
        "Listing events: The company has filed a series of director and share\u2011holding disclosures over the last six months, signalling a period of internal reshuffling.",
        "Corporate governance: Two separate director changes and a series of PDMR filings indicate that the board is actively managing ownership stakes, but no new capital raise has been announced.",
        "Operational updates: The most recent trading update and AGM results offer no revenue figures or growth milestones, leaving the operational picture opaque."
      ],
      "crowd_tape": {
        "dominant_theme": "The community is largely silent; the handful of posts that exist are split between a small group of optimists who see potential in the risk\u2011management niche and a larger group of sceptics who point to the lack of revenue and the stock\u2019s near\u2011zero price.",
        "bull_narrative": "Bulls argue that the company\u2019s technology platform could be a hidden gem for mid\u2011cap firms looking to upgrade their risk tools, and they hope a future placement or partnership will unlock value.",
        "bear_narrative": "Bears warn that the absence of any tangible financial results, coupled with the company\u2019s steep decline, makes it a high\u2011risk speculative play with little upside.",
        "sentiment_shift": "Two weeks ago there was a brief spike in chatter around the AGM, but it faded rapidly as no concrete data emerged; the community has since moved on."
      },
      "attention_check": "Google Trends shows a flatline of interest, with no peaks in the last month and a 0/100 interest score. Social media volume is zero, confirming that the story has lost oxygen and is no longer on the radar of most traders."
    },
    "expect_next": {
      "near_term_catalysts": [
        "Q3 2026 Results (Aug): The first revenue print would be a decisive factor for the bullish case.",
        "Potential Share Placement (Oct): A new equity issue could provide the capital needed for scaling and may move the price above the current level."
      ],
      "watch_for": "Monitor any sudden director sell\u2011offs, fresh PDMR filings, or rumours of a placement; any of these would either fuel the bullish narrative or confirm the bearish view that the company is in a pre\u2011revenue, cash\u2011constrained state.",
      "timing_regime": "Exhausted \u2013 the story has lost momentum, and the stock\u2019s technical profile shows no sign of a rebound; any entry would be a high\u2011risk, low\u2011probability bet."
    },
    "buy_vs_sell": {
      "lean": "Bearish",
      "bull_case": "If the company manages to secure a first revenue stream or a strategic partnership in the next quarter, it could spark a price rally that would justify a small speculative bet. The key trigger would be a clear financial update that demonstrates product adoption and revenue generation.",
      "bear_case": "The lack of any revenue, the steep decline in price, and the absence of a clear catalyst make the risk of a further drop very high. The stock\u2019s zero volatility and flat trend suggest that there is no underlying support for a rebound.",
      "risk_reward": "Poor risk/reward \u2013 the upside is speculative and capped at a modest price move, while the downside is virtually unbounded given the current price level."
    },
    "playbook": {
      "if_bullish": "Enter a very small position (2\u20133\u202f% of the portfolio) only if a credible revenue announcement surfaces. Set a tight stop\u2011loss at 0.05\u202fp to protect against a further decline.",
      "if_watching": "Wait for the next AGM or Q3 results; if a revenue print or a new partnership is announced, consider a cautious entry on a dip with a stop just below the placement price.",
      "if_passing": "The story is too early and lacks traction; no clear catalyst or revenue visibility exists, so it is safer to stay out and look for more promising micro\u2011cap setups."
    },
    "bottom_line": "Pass\u2014story losing momentum, no clear catalyst, better setups elsewhere.",
    "_selected_rns": [
      {
        "title": "Director/PDMR Shareholding",
        "date": "2025-12-23T00:00:00",
        "importance_score": 0.8410714285714285,
        "time_bucket": "MID",
        "rns_number": ""
      },
      {
        "title": "Holding(s) in Company",
        "date": "2026-01-05T00:00:00",
        "importance_score": 0.6877777777777778,
        "time_bucket": "MID",
        "rns_number": ""
      },
      {
        "title": "Directorate Change",
        "date": "2025-10-20T00:00:00",
        "importance_score": 0.6769444444444443,
        "time_bucket": "MID",
        "rns_number": ""
      },
      {
        "title": "Result of AGM",
        "date": "2025-10-13T00:00:00",
        "importance_score": 0.6633333333333333,
        "time_bucket": "MID",
        "rns_number": ""
      },
      {
        "title": "Trading Update",
        "date": "2025-12-18T00:00:00",
        "importance_score": 0.6527777777777778,
        "time_bucket": "MID",
        "rns_number": ""
      },
      {
        "title": "Final Results",
        "date": "2025-09-17T00:00:00",
        "importance_score": 0.6524603174603174,
        "time_bucket": "MID",
        "rns_number": ""
      },
      {
        "title": "Notice of Results & Retail Investor Presentation",
        "date": "2025-09-08T00:00:00",
        "importance_score": 0.5952777777777777,
        "time_bucket": "MID",
        "rns_number": ""
      },
      {
        "title": "Grant of Options and PDMR dealing",
        "date": "2025-07-10T00:00:00",
        "importance_score": 0.478611111111111,
        "time_bucket": "LONG",
        "rns_number": ""
      },
      {
        "title": "Neighbourhood Health Service Simulation",
        "date": "2025-06-12T00:00:00",
        "importance_score": 0.2852777777777778,
        "time_bucket": "LONG",
        "rns_number": ""
      },
      {
        "title": "Half-year Report",
        "date": "2025-02-25T00:00:00",
        "importance_score": 0.0772222222222222,
        "time_bucket": "LONG",
        "rns_number": ""
      }
    ]
  },
  "crashdash": {
    "industry_intelligence": {
      "category": "BIOTECH_PHARMA",
      "name": "Biotech & Pharma",
      "icon": "\ud83e\uddec",
      "color": "#10b981",
      "crash_patterns": [
        "Clinical trial failures (Phase 1/2/3)",
        "FDA/EMA rejection or delay",
        "Safety concerns or adverse events",
        "Patent expiry or IP challenges",
        "Funding gaps (cash runway concerns)"
      ],
      "recovery_paths": [
        "Positive trial data (efficacy endpoints met)",
        "Regulatory approvals (FDA/EMA)",
        "Partnership deals (big pharma licensing)",
        "Orphan drug designation or fast track",
        "New trial initiations (pipeline expansion)"
      ],
      "active_patterns": [
        "FDA/EMA rejection or delay",
        "Safety concerns or adverse events",
        "Patent expiry or IP challenges"
      ],
      "relevant_rns_count": 0,
      "key_metrics": [
        "Clinical stage (preclinical, Phase 1/2/3, commercialized)",
        "Cash runway (months until next funding)",
        "Addressable market size (indication)",
        "Trial enrollment progress",
        "Intellectual property strength"
      ]
    },
    "panic_analysis": {
      "panic_score": 46.9,
      "signal": "MODERATE_FEAR",
      "interpretation": "\ud83d\udfe1 Cautious sentiment - assess risk/reward",
      "breakdown": {
        "price_destruction": 16.9,
        "volume_death": 14,
        "social_silence": 6,
        "news_sentiment": 10
      },
      "is_opportunity": false,
      "opportunity_reason": "\ud83d\udcca Moderate fear detected - monitor for escalation"
    },
    "fear_vs_facts": {
      "fear_points": [],
      "facts_points": [],
      "verdict": "\u2696\ufe0f Mixed signals - Fear and facts balanced, wait for clarity"
    },
    "crashhunter_signals": [
      {
        "type": "CONFIRMED",
        "icon": "\u2705",
        "text": "Confirmed",
        "color": "#10b981"
      }
    ],
    "catalyst_pipeline": [
      {
        "type": "rns",
        "date": "5th Jan 2026",
        "title": "Holding(s) in Company",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "rns",
        "date": "23rd Dec 2025",
        "title": "Holding(s) in Company",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "rns",
        "date": "23rd Dec 2025",
        "title": "Director/PDMR Shareholding",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "rns",
        "date": "18th Dec 2025",
        "title": "Trading Update",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "rns",
        "date": "20th Oct 2025",
        "title": "Directorate Change",
        "status": "published",
        "icon": "\ud83d\udce2"
      }
    ],
    "decision_matrix": {
      "decision": "AVOID",
      "reason": "\u274c HOLD/WATCH - timing CONFIRMED",
      "checklist": [
        {
          "criterion": "Panic Score",
          "value": "47/100",
          "pass": false,
          "icon": "\ud83d\udfe2"
        },
        {
          "criterion": "Timing Regime",
          "value": "CONFIRMED",
          "pass": true,
          "icon": "\u2705"
        },
        {
          "criterion": "APEX Quality",
          "value": "38/100",
          "pass": false,
          "icon": "\u26a0\ufe0f"
        },
        {
          "criterion": "Data Confidence",
          "value": "40/100",
          "pass": true,
          "icon": "\ud83c\udfaf"
        },
        {
          "criterion": "Industry Pattern",
          "value": "3 active",
          "pass": true,
          "icon": "\ud83e\uddec"
        }
      ],
      "pass_rate": "3/5"
    },
    "contrarian_panic": {
      "total_score": 27,
      "band": "\u26aa LOW COMPRESSION (Early/Weak)",
      "components": {
        "compression": {
          "score": 17,
          "max": 40,
          "signals_30d": 2,
          "signals_60d": 6,
          "signals_90d": 6,
          "signals_per_week": 0.46,
          "total_signals": 16,
          "rsi_extreme_count": 5,
          "rsi_ultra_count": 5,
          "escalation_count": 1,
          "density_score": 3,
          "rsi_score": 10,
          "escalation_score": 4,
          "description": "0.5 signals/week | 5 RSI<20 | 1 escalations | \ud83d\udcca MODERATE COMPRESSION"
        },
        "intensification": {
          "score": 5,
          "max": 20,
          "recent_types": [
            "CRASH ZONE BOTTOM",
            "DEEP CRASH BOTTOM",
            "CRASH ZONE BOTTOM"
          ],
          "escalating": false,
          "sustained": false,
          "current_intensity": 1,
          "pattern": "NORMAL CRASH LEVEL"
        },
        "volume_death": {
          "score": 5,
          "max": 15,
          "relative_volume": 2.24,
          "description": "Elevated volume - Some activity"
        },
        "pop_potential": {
          "score": 0,
          "max": 15,
          "best_historical_rally": 38.9,
          "avg_rally": 13.3,
          "signal_count": 16,
          "description": "Weak history (39%)"
        },
        "accumulation": {
          "score": 0,
          "max": 10,
          "has_accumulation": false,
          "bars_since_accum": 0,
          "description": "No accumulation"
        }
      },
      "ticker": "FDBK.L",
      "signal_date": "2025-10-23",
      "total_signals_history": 16
    }
  },
  "scoring_breakdown": {
    "apex_factors": [
      "Technical quality: +16 (AI_Technical_Score=13.0/20)",
      "Drawdown reversion potential: +17 (Drawdown_Pct=84.6%)",
      "Volume confirmation: +10 (Relative_Volume=2.2)",
      "Pattern reliability: +5 (Rally_Count=1.0)",
      "Upside history: +5 (best_rally_pct=39%)",
      "Split risk penalty: -15 (HIGH, age_factor=1.00)"
    ],
    "technical_score": {
      "points": 16,
      "ai_score": 13.0,
      "reason": "AI Technical Score 13.0/20 translates to 16/25 points"
    },
    "drawdown_score": {
      "points": 17,
      "drawdown_pct": 84.58,
      "reason": "Drawdown of 84.6% gives 17/20 points"
    },
    "volume_score": {
      "points": 10,
      "rel_volume": 2.24,
      "reason": "Relative volume 2.24x gives 10 points"
    },
    "pattern_score": {
      "points": 5,
      "rally_count": 1.0,
      "reason": "1.0 historical rallies gives 5/15 points"
    },
    "upside_score": {
      "points": 5,
      "best_rally_pct": 38.92,
      "reason": "Best rally of 39% gives 5/20 points"
    },
    "penalties": {
      "total": -15,
      "items": [
        "Split risk penalty: -15 (HIGH, age_factor=1.00)"
      ]
    }
  },
  "reasons_buy_sell": {
    "reasons_to_buy": [
      {
        "reason": "Proven winner - previously hit lock-in target",
        "tag": "MED",
        "evidence": [
          "lock_in_reached=True"
        ]
      }
    ],
    "reasons_to_sell": [
      {
        "reason": "Stale signal - not for active trading",
        "tag": "HIGH",
        "evidence": [
          "status=historical",
          "signal_date=2025-10-23"
        ]
      }
    ]
  },
  "trade_plan": {
    "trader_plan": {
      "style": "Active trade",
      "action": "HOLD/WATCH",
      "sizing": "1-3% position based on conviction",
      "risk": "Stop below recent support / invalidation level",
      "profit_taking": "Scale out into strength: 25% @ +15%, 50% @ +50%, trail runner"
    },
    "investor_plan": {
      "allowed": false,
      "thesis_conditions": "Unlock after AI triangulation + CONFIRMED timing",
      "hold_window": "N/A",
      "risk_management": "N/A"
    }
  },
  "exhaustion": {
    "regime": "CONFIRMED",
    "run_multiple": 0.54,
    "current_run_pct": 21.08,
    "avg_historical_run_pct": 38.92
  },
  "history_snapshot": {
    "previous_report_date": null,
    "score_change": null,
    "confidence_change": null,
    "new_events_count": 0,
    "new_rns_titles": []
  },
  "commentary": {
    "executive_summary": "Note: this report used historical signals only \u2014 live triangulation (RNS, social, Trends) was not available. Current setup looks like CONFIRMED with an APEX score of 38/100. Historically there have been 1 rallies (avg. 39%); the position is now +21.1%. Practical take: this is interesting but unconfirmed \u2014 wait for an AI snapshot or clear confirmation before committing size.",
    "bull_case": [
      "No obvious upside without a catalyst"
    ],
    "bear_case": [
      "No immediate red flags, but keep stops tight"
    ],
    "timing_translation": "Move has started \u2014 this is the actionable window if your thesis remains intact.",
    "confidence_explained": "Confidence 40/100 \u2014 data triangulated from RNS, social and Trends."
  },
  "data_quality": {
    "sources_present": {
      "snapshot_json": false,
      "daily_enrichment_row": true,
      "historical_profile": true,
      "metadata": true,
      "triangulation_events": true,
      "ai_insights": true
    },
    "missing_data": [
      "AI insights from Groq LLM"
    ],
    "confidence_impact": "HIGH",
    "disclaimer": "Data provided as-is. Not financial advice. AIM micro-caps carry significant volatility risk."
  }
}